Get the Stockscreener App
23.44
0.30%
0.07
After Hours:
23.44
Assertio Holdings Inc stock is traded at $23.44, with a volume of 284.85K.
It is up +0.30% in the last 24 hours and up +30.01% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in comprehensive commercial capabilities, offering differentiated products designed to address patients' needs. Its focus is on supporting patients by marketing products mainly in the oncology market. The Company operates in the business within one reportable segment, relating to the sale of pharmaceutical products to its customers.
See More
Previous Close:
$23.37
Open:
$23.38
24h Volume:
284.85K
Relative Volume:
1.07
Market Cap:
$151.47M
Revenue:
$118.71M
Net Income/Loss:
$-30.38M
P/E Ratio:
-7.9633
EPS:
-2.9435
Net Cash Flow:
$-28.18M
1W Performance:
+0.51%
1M Performance:
+30.01%
6M Performance:
+117.28%
1Y Performance:
+120.00%
1-Day Range:
$23.38
$23.45
1-Week Range:
$23.32
$23.46
52-Week Range:
$8.61
$23.46
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
23.44 | 151.02M | 118.71M | -30.38M | -28.18M | -2.9435 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-09-26 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
Assertio Announces Amended And Restated Merger Agreement With Garda Therapeutics >ASRT - Moomoo
Assertio Deadline Alert - TMX Newsfile
$HAREHOLDER ALERT: The M&A Class Action Continues to Investigate the Merger-ASRT, SILA, KW, and UNF - The Malaysian Reserve
ASRT Stock Price, Quote & Chart | ASSERTIO HOLDINGS INC (NASDAQ:ASRT) - ChartMill
Assertio gets sweetened $153M buyout offer from Garda Therapeutics - MSN
Zydus buys Assertio for $166 million to deepen US specialty and oncology presence - MSN
Assertio Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Assertio Holdings, Inc.ASRT - Business Wire
Contact UsConcord Monitor - FinancialContent
Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? - Sahm
Zydus offers $23.50 cash per share to buy Assertio (ASRT) — Board backs deal - Stock Titan
Zydus (NASDAQ: ASRT) offers $23.50 per share in cash tender for Assertio - Stock Titan
Assertio Therapeutics to be acquired by Zydus Worldwide - TipRanks
Assertio Holdings to be acquired by Zydus Worldwide in $23.50 per share cash deal - Investing.com Australia
Assertio Holdings, Inc. Announces Pre-Commencement Issuer Tender Offer and Merger Update – SEC Form 8-K Filing May 18, 2026 - Minichart
Assertio to be acquired in $23.50/share cash tender offer by Zydus - TradingView
Assertio (ASRT) to be acquired for $23.50 per share; tender offer starts May 18, 2026 - Stock Titan
Assertio (ASRT) moves 17.0% higher: Will this strength last? - MSN
Assertio's Acquisition: What's the Deal and Why Now - Kavout
Zydus Expands US Cancer Drug Business with Assertio Acquisition - Chemical Industry Digest
Director of Assertio (NASDAQ: ASRT) makes 13,332-share stock gift - Stock Titan
Assertio Holdings (ASRT) price target decreased by 12.42% to 24.34 - MSN
Zydus-Assertio Deal: US Revenue Might Peak In 2029 But Rolvedon Promises More - Citeline News & Insights
symbol__ Stock Quote Price and Forecast - CNN
Zydus Lifesciences Buys Assertio In US To Strengthen Cancer Treatment Push - Siliconindia
Zydus to Acquire US Oncology Pharma Firm Assertio in USD 166 Million Deal - Medical Dialogues
Zydus (ASRT) proposes $23.50 cash tender offer; Schedule TO forthcoming - Stock Titan
Zydus to acquire Assertio in $166m deal - Yahoo Finance
Zydus Life spurts as board to mull share buyback; arm signs deal to acquire Assertio - Business Standard
Zydus to acquire US firm Assertio for $166.4 million - Ahmedabad Mirror
Buyback and Acquisition Announcement: This pharma company shares BIG update for shareholders - Zee Business
Zydus Lifesciences shares jump 6% on buyback buzz; co announces $166 mn Assertio acquisition - The Economic Times
Zydus Lifesciences acquires Assertio in ₹1,570 crore US expansion push - domain-b.com
Zydus Worldwide DMCC to Acquire Entire Stake in Assertio Holdings for USD 166.4 Million - scanx.trade
Zydus to acquire US-based Assertio for $166.4 M to support oncology therapies - BioSpectrum India
Zydus Lifesciences arm to acquire US oncology firm Assertio - VCCircle
Zydus to buy Assertio for $166.4 million - The Economic Times
Zydus to acquire Assertio in all-cash tender offer - Express Pharma
Zydus Lifesciences to acquire Assertio for USD 166.4 mn - ET BrandEquity
Zydus and Assertio Holdings enter into an agreement for Zydus to acquire Assertio in an all-cash tender offer - IndiaMedToday
Zydus Lifesciences to Acquire Assertio for $166.4 Million - outlookbusiness.com
Zydus buys US specialty drugmaker Assertio in Rs 1,600 crore all-cash deal - TradingView
Zydus Lifesciences arm to acquire U.S. oncology firm Assertio for $166 million - The Hindu
ASRT | Assertio Holdings, Inc. Common FinancialsIncome Statement - Quiver Quantitative
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.92%
4.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):